Euclidean Capital LLC reported 11 holdings worth US$440M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Euclidean Capital LLC reported 11 holdings worth US$440M as of Jun 30, 2026. Largest: Oric Pharmaceuticals, Inc., Foghorn Therapeutics Inc. and Pmv Pharmaceuticals, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 11
- Value as reported
- US$440M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Oric Pharmaceuticals, Inc. | 989K | US$10.7M | 2.4% |
| Foghorn Therapeutics Inc. | 1.57M | US$7.68M | 1.7% |
| Pmv Pharmaceuticals, Inc. | 2.63M | US$3.52M | 0.80% |
| Alector, Inc. | 1.31M | US$2.63M | 0.60% |
| Surrozen, Inc. | 87,696 | US$2.28M | 0.52% |
| Tenaya Therapeutics, Inc. | 1.02M | US$751K | 0.17% |